Trade

with

Albany Molecular Research Inc
(NASDAQ: AMRI)
AdChoices
23.18
+0.53
+2.34%
After Hours :
-
-
-

Open

23.00

Previous Close

22.65

Volume (Avg)

221.72k (306.25k)

Day's Range

22.84-23.56

52Wk Range

9.71-23.56

Market Cap.

735.63M

Dividend Rate ( Yield )

-

Beta

1.76

Shares Outstanding

32.48M

P/E Ratio (EPS)

44.05 (0.51)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Biotechnology
Highlights
Analyst Recommendation: Not Available
    • Revenue

    • 246.58M

    • Net Income

    • 12.68M

    • Market Cap.

    • 735.63M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 6.31

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 1.76

    • Forward P/E

    • -

    • Price/Sales

    • 2.78

    • Price/Book Value

    • 2.90

    • Price/Cash flow

    • 54.05

      • EBITDA

      • 36.83M

      • Return on Capital %

      • 4.06

      • Return on Equity %

      • 6.94

      • Return on Assets %

      • 4.06

      • Book Value/Share

      • 7.80

      • Shares Outstanding

      • 32.48M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      -
      Not Available
        • 1 Year Price Target

        • -

        • Credit Rating

        • -

        • Analysts

        • 0

        • EPS Estimate

        • -

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 15.00

          • 40.73

          • Net Income

            YTD/YTD (last year)

          • -

          • 17.04

          • Net Income

            Q/Q (last year)

          • -

          • 98.90

          • Sales (Revenue)

            5-Year Annual Average

          • 1.47

          • 63.43

          • Net Income

            5-Year Annual Average

          • -9.20

          • 10.65

          • Dividends

            5-Year Annual Average

          • -

          • 15.81

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 30.18

            • 82.75

            • Pre-Tax Margin

            • 7.26

            • 39.38

            • Net Profit Margin

            • 6.31

            • 31.33

            • Average Gross Margin

              5-Year Annual Average

            • 25.50

            • 82.99

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -11.50

            • 33.42

            • Average Net Profit Margin

              5-Year Annual Average

            • -10.50

            • 199.05B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.48

              • 0.76

              • Current Ratio

              • 5.20

              • 2.92

              • Quick Ratio

              • 3.90

              • 2.35

              • Interest Coverage

              • 3.83

              • 38.02

              • Leverage Ratio

              • 2.05

              • 2.21

              • Book Value/Share

              • 7.80

              • 4.79

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 43.67

                • 243.90

                • P/E Ratio 5-Year High

                • 45.41

                • 634.30

                • P/E Ratio 5-Year Low

                • 4.05

                • 124.82

                • Price/Sales Ratio

                • 2.76

                • 9.29

                • Price/Book Value

                • 2.88

                • 8.39

                • Price/Cash Flow Ratio

                • 54.05

                • 49.75

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • 6.94

                    (-7.70)

                  • 37.63

                    (27.20)

                  • Return on Assets %

                    (5-Year Average)

                  • 4.06

                    (-6.20)

                  • 17.22

                    (13.81)

                  • Return on Capital %

                    (5-Year Average)

                  • 7.34

                    (-7.70)

                  • 21.78

                    (17.31)

                  • Income/Employee

                  • 12.56k

                  • 117.08k

                  • Inventory Turnover

                  • 4.48

                  • 1.48

                  • Asset Turnover

                  • 0.64

                  • 0.55

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  20.18M
                  Operating Margin
                  8.18
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  54.05
                  Ownership

                  Institutional Ownership

                  -

                  Top 10 Institutions

                  57.47%

                  Mutual Fund Ownership

                  30.14%

                  Float

                  73.96%

                  5% / Insider Ownership

                  20.48%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • DFA US Small Cap Value II Portfolio

                  •  

                    873,537

                  • 0.00

                  • 2.69

                  • Royce Opportunity Fund

                  •  

                    700,710

                  • -9.82

                  • 2.16

                  • iShares Core S&P Small-Cap (AU)

                  •  

                    476,850

                  • 0.57

                  • 1.48

                  • Legg Mason Royce US Small Cap Opp

                  •  

                    435,000

                  • 3.08

                  • 1.34

                  • iShares Nasdaq Biotechnology

                  •  

                    422,182

                  • -0.24

                  • 1.31

                  • Vanguard Total Stock Mkt Idx

                  •  

                    395,242

                  • 0.00

                  • 1.22

                  • iShares Russell 2000 (AU)

                  •  

                    358,297

                  • -1.80

                  • 1.11

                  • DFA U.S. Micro Cap Portfolio

                  •  

                    345,122

                  • 1.08

                  • 1.06

                  • SEB Concept BioTech

                  •  

                    263,200

                  • 14.63

                  • 0.81

                  • Vanguard Extended Market Index Fund

                  •  

                    252,356

                  • 0.00

                  • 0.78

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Bessemer Trust Co Of Delaware, N.a.

                  •  

                    4,293,289

                  • -5.96%

                  • 13.27

                  • Dimensional Fund Advisors, Inc.

                  •  

                    2,716,245

                  • +3.31%

                  • 8.38

                  • Visium Asset Management LLC

                  •  

                    2,170,000

                  • -31.11%

                  • 6.69

                  • Wellington Management Company, LLP

                  •  

                    1,564,852

                  • -6.66%

                  • 4.83

                  • BlackRock Fund Advisors

                  •  

                    1,519,059

                  • +46.82%

                  • 4.69

                  • Evercore Wealth Management, LLC

                  •  

                    1,331,480

                  • 0.00%

                  • 4.11

                  • Royce & Associates, LLC

                  •  

                    1,315,610

                  • -2.16%

                  • 4.06

                  • Acadian Asset Management LLC

                  •  

                    1,173,743

                  • -6.79%

                  • 3.61

                  • Millennium Management LLC

                  •  

                    910,133

                  • -10.96%

                  • 2.81

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Biotechnology

                  Type

                  Speculative Growth

                  Style

                  Small Growth

                  Albany Molecular Research Inc is a Delaware corporation incorporated on June 20, 1991. It is a contract research and manufacturing organization providing customers integrated drug discovery, development and manufacturing services. Th...moree Company provides services and technologies that support the discovery and development of pharmaceutical products and the manufacturing of Active Pharmaceutical Ingredients (API) and drug product for existing and experimental new drugs, as well as research, development and manufacturing for the agrochemical and other industries. With locations in the United States, Europe, and Asia, it maintains geographic proximity and flexible cost models. The Company has organized its activities into two distinct segments: Large Scale Manufacturing (LSM) and Discovery, Drug Developme...morent and Small-Scale Manufacturing (DDS). Its LSM activities include pilot- to commercial-scale production of active pharmaceutical ingredients and intermediates, sterile syringe and vial filling, and high potency and controlled substance manufacturing. Its remaining activities, including drug lead discovery, in vitro biology and DMPK, lead optimization, drug development, and small-scale commercial manufacturing, represent its DDS business segment. Its Drug Discovery Services includes assay development and design, screening, natural product services, custom synthesis and library synthesis, medicinal chemistry, bioanalytical services, among others. Its customers include pharmaceutical companies and biotechnology companies, as well as government research entities and non-profit organizations, which are a growing segment of its customer base. It also sells to a more limited extent, to companies who are in the businesses of agriculture, fine chemicals, contract chemical manufacturing, medical devices, and flavoring and cosmetics. The Company competes with contract research companies, contract drug manufacturing companies, research and academic institutions and with the internal research departments of biotechnology companies. The manufacture, transportation and storage of its products are subject to certain international, Federal, state and local laws and regulations.lessless

                  Key People

                  William S. Marth

                  CEO/Director/President

                  Dr. Thomas E. D'Ambra,PhD

                  Chairman of the Board/Co-Founder/Director

                  Mr. Michael Nolan

                  CFO/Chief Accounting Officer/Treasurer/Senior Vice President

                  Mr. Brian D. Russell

                  Vice President, Divisional

                  Arthur J. Roth

                  Director

                  • Albany Molecular Research Inc

                  • 26 Corporate Circle

                  • Albany, NY 12203

                  • USA.Map

                  • Phone: +1 518 512-2000

                  • Fax: -

                  • amriglobal.com

                  Incorporated

                  1991

                  Employees

                  1,282

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: